These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

944 related articles for article (PubMed ID: 18397199)

  • 1. Developing antibacterial vaccines in genomics and proteomics era.
    Kaushik DK; Sehgal D
    Scand J Immunol; 2008 Jun; 67(6):544-52. PubMed ID: 18397199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using genomics to develop novel antibacterial therapeutics.
    Nagaraj NS; Singh OV
    Crit Rev Microbiol; 2010 Nov; 36(4):340-8. PubMed ID: 20670176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New ways to identify novel bacterial antigens for vaccine development.
    Movahedi AR; Hampson DJ
    Vet Microbiol; 2008 Sep; 131(1-2):1-13. PubMed ID: 18372122
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biotechnology and vaccines: application of functional genomics to Neisseria meningitidis and other bacterial pathogens.
    Serruto D; Adu-Bobie J; Capecchi B; Rappuoli R; Pizza M; Masignani V
    J Biotechnol; 2004 Sep; 113(1-3):15-32. PubMed ID: 15380644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genome-derived vaccines.
    De Groot AS; Rappuoli R
    Expert Rev Vaccines; 2004 Feb; 3(1):59-76. PubMed ID: 14761244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic technology in the design of new effective antibacterial vaccines.
    Jagusztyn-Krynicka EK; Dadlez M; Grabowska A; Roszczenko P
    Expert Rev Proteomics; 2009 Jun; 6(3):315-30. PubMed ID: 19489702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of virulence factors of pathogenic bacteria.
    Wu HJ; Wang AH; Jennings MP
    Curr Opin Chem Biol; 2008 Feb; 12(1):93-101. PubMed ID: 18284925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vaccines in the era of genomics: the pneumococcal challenge.
    Barocchi MA; Censini S; Rappuoli R
    Vaccine; 2007 Apr; 25(16):2963-73. PubMed ID: 17324490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proteomics approaches towards antigen discovery and vaccine development.
    Klade CS
    Curr Opin Mol Ther; 2002 Jun; 4(3):216-23. PubMed ID: 12139306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial genomics and vaccine design.
    Sampson SL; Rengarajan J; Rubin EJ
    Expert Rev Vaccines; 2003 Jun; 2(3):437-45. PubMed ID: 12903808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach.
    Mora M; Donati C; Medini D; Covacci A; Rappuoli R
    Curr Opin Microbiol; 2006 Oct; 9(5):532-6. PubMed ID: 16890009
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bioinformatics: how it is being used to identify bacterial vaccine candidates.
    Zagursky RJ; Olmsted SB; Russell DP; Wooters JL
    Expert Rev Vaccines; 2003 Jun; 2(3):417-36. PubMed ID: 12903807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Designing the next generation of vaccines for global public health.
    Bagnoli F; Baudner B; Mishra RP; Bartolini E; Fiaschi L; Mariotti P; Nardi-Dei V; Boucher P; Rappuoli R
    OMICS; 2011 Sep; 15(9):545-66. PubMed ID: 21682594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The impact of genomics on vaccine design.
    Scarselli M; Giuliani MM; Adu-Bobie J; Pizza M; Rappuoli R
    Trends Biotechnol; 2005 Feb; 23(2):84-91. PubMed ID: 15661345
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Novel targets for the future development of antibacterial agents.
    McDevitt D; Payne DJ; Holmes DJ; Rosenberg M
    Symp Ser Soc Appl Microbiol; 2002; (31):28S-34S. PubMed ID: 12481826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Developing vaccines in the era of genomics: a decade of reverse vaccinology.
    Seib KL; Zhao X; Rappuoli R
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():109-16. PubMed ID: 22882709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mining genomes and mapping proteomes: identification and characterization of protein subunit vaccines.
    Chakravarti DN; Fiske MJ; Fletcher LD; Zagursky RJ
    Dev Biol (Basel); 2000; 103():81-90. PubMed ID: 11214257
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Antigenome technology: rapid and comprehensive identification and validation of antigens as putative components in vaccines against bacterial pathogens].
    Henics T; Nagy E
    Orv Hetil; 2005 Oct; 146(43):2209-14. PubMed ID: 16323567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using the genome to understand pathogenicity.
    Field D; Hughes J; Moxon ER
    Methods Mol Biol; 2004; 266():261-87. PubMed ID: 15148423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infectomics: genomics and proteomics of microbial infections.
    Huang SH; Triche T; Jong AY
    Funct Integr Genomics; 2002 Apr; 1(6):331-44. PubMed ID: 11957108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 48.